Background
Severe hypoglycemia, or dangerously low blood sugar, is one of the most feared complications of diabetes treatment. It can cause confusion, loss of consciousness, seizures, injury, and in some cases require emergency treatment. The risk is especially important in people with type 2 diabetes who use insulin or sulfonylureas, two treatment classes that can lower glucose too much if dosing, meals, activity, or awareness of symptoms are not well matched.
In type 1 diabetes, psychoeducational programs have been shown to help reduce severe hypoglycemia by improving recognition of warning signs, self-management skills, and decision-making around insulin use, exercise, and eating. However, whether similar approaches add benefit for adults with type 2 diabetes has been less clear. This trial was designed to test whether adding structured psychoeducation to proactive nurse-led care would reduce severe hypoglycemia more than proactive care alone.
Study design
The Preventing Severe Hypoglycemia in Adults with Type 2 Diabetes (PHT2) trial was a randomized controlled study. Adults with type 2 diabetes were enrolled if they were taking insulin or a sulfonylurea and had either experienced a severe hypoglycemic event in the previous 12 months or had impaired awareness of hypoglycemia, meaning they did not reliably notice low blood sugar symptoms.
Participants were randomly assigned to one of two groups:
1. Proactive care management (PC): nurse-led proactive care focused on hypoglycemia prevention and diabetes self-management support.
2. Proactive care plus psychoeducation (PC+): the same proactive care, plus my hypo compass, a psychoeducational intervention designed to improve hypoglycemia awareness and prevention skills.
The main outcome was self-reported severe hypoglycemia over 12 months, measured at 14 months. Secondary measures included less severe glucose-confirmed episodes and other hypoglycemia-related outcomes.
Who took part
A total of 259 adults joined the trial. The average age was 67.2 years, with a standard deviation of 10.6 years, and 61% were women. About 92% of participants, or 230 people, completed the study, which supports the reliability of the findings.
Before the study began, severe hypoglycemia had already been common in both groups. In the 12 months before baseline, 34.1% of people in the PC group and 24.8% in the PC+ group reported at least one severe event. This shows that the study enrolled a high-risk population who could reasonably benefit from preventive support.
Main results
At 14 months, both groups had fewer severe hypoglycemia events than before the study, but the difference between the two interventions was not statistically significant.
In the proactive care group, 16.1% reported at least one severe hypoglycemia event during follow-up. In the proactive care plus psychoeducation group, the figure was 11.6%. The adjusted relative risk was 0.72, with a 95% confidence interval from 0.39 to 1.30. The adjusted absolute risk difference was -4.6 percentage points, with a 95% confidence interval from -13.0 to 3.7.
In practical terms, the numbers suggest a possible benefit from adding psychoeducation, but the study could not confirm that the difference was strong enough to rule out chance.
For level 2 hypoglycemia, defined as glucose below 54 mg/dL for at least 15 minutes, the PC+ group appeared to do better on the absolute risk scale. The adjusted relative risk was 0.46, with a 95% confidence interval from 0.20 to 1.03, and the adjusted absolute risk difference was -11.3%, with a 95% confidence interval from -21.7 to -0.8. This means the psychoeducation program may have reduced biochemical hypoglycemia, even though the trial did not show a clear statistically significant reduction in severe events.
No other secondary outcomes differed significantly between groups.
What the results mean
The most important finding is that proactive nurse care helped reduce severe hypoglycemia in this high-risk group, and adding psychoeducation did not produce a clearly additional benefit for the primary outcome. Both groups experienced about a 50% reduction in severe hypoglycemia compared with baseline, which is clinically meaningful.
There are several possible reasons why the added psychoeducational program did not show a stronger effect. First, proactive care itself may have been powerful enough to lower risk substantially, leaving less room for improvement. Second, the study may have been underpowered, meaning it may not have included enough participants to detect a modest difference between groups. Third, severe hypoglycemia is influenced by many factors beyond patient knowledge, including medication choice, kidney function, meal patterns, physical activity, cognitive status, and social support.
The findings also suggest that psychoeducation may still be useful for reducing lower-level hypoglycemia or helping people better recognize and respond to early warning signs, even if the effect on severe episodes was not definitive in this study.
Clinical implications
For clinicians, this trial reinforces several practical points. Adults with type 2 diabetes who use insulin or sulfonylureas and have a history of severe hypoglycemia or impaired awareness should be considered a high-risk group. They may benefit from active follow-up, medication review, individualized glucose targets, and education about prevention strategies.
A proactive care model can include:
– Reviewing insulin or sulfonylurea doses and timing
– Assessing meal regularity, alcohol use, and physical activity
– Teaching patients how to recognize, treat, and prevent low blood sugar
– Considering whether less hypoglycemia-prone medications are appropriate
– Encouraging glucose monitoring, including continuous glucose monitoring when available and appropriate
– Checking for factors that may reduce awareness of hypoglycemia, such as repeated episodes or older age
This study suggests that nurse-led proactive management alone can make a meaningful difference. Psychoeducation may still be valuable as part of comprehensive care, especially for patients with repeated lows, anxiety about hypoglycemia, or difficulty interpreting symptoms.
Strengths and limitations
This trial had several strengths. It was randomized, it enrolled a clinically relevant high-risk population, and it achieved a high completion rate. The study also used a pragmatic approach that reflects real-world care, making the results useful for everyday practice.
However, there are limitations. The primary outcome was self-reported, which can introduce recall bias. The trial may not have been large enough to identify smaller but still important differences between groups. Also, because the population was high risk and already receiving active support, the results may not generalize to lower-risk adults with type 2 diabetes or to settings without proactive nurse involvement.
Bottom line
In adults with type 2 diabetes at high risk for severe hypoglycemia, proactive nurse care reduced severe events by about half over 12 months. Adding a psychoeducational program did not significantly lower severe hypoglycemia further, although it may have reduced some less severe glucose-defined episodes. The findings support proactive, individualized hypoglycemia prevention as a key part of diabetes care, while suggesting that psychoeducation alone may not add a large additional benefit in this setting.
Trial information
ClinicalTrials.gov Identifier: NCT04863872
Citation: Ralston JD, Anderson ML, Ng J, Bashir A, Ehrlich K, Burns-Hunt D, Cotton M, Hansell L, Hsu C, Hunt H, Karter AJ, Levy SM, Ludman E, Madziwa L, Omura EM, Rogers K, Sevey B, Shaw JAM, Shortreed SM, Speight J, Sweeny A, Tschernisch K, Tschernisch S, Yarborough L. Preventing Severe Hypoglycemia in Type 2 Diabetes: Randomized Controlled Trial of Proactive Care With Versus Without Psychoeducation. Journal of General Internal Medicine. 2026-05-12. PMID: 42118187.
